Gitlab Inc.
For the period ended Jan 31, 2025. Filed Mar 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 21, 2025
GTLB$46.66-1.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
| Fiscal Year Ended January 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||
| Net loss, including amounts attributable to noncontrolling interest | $(9,119) | $(429,536) | $(181,792) |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||
| Stock-based compensation expense | 185,899 | 163,049 | 122,567 |
| Change in fair value of acquisition related contingent consideration | 3,750 | — | (1,722) |
| Charitable donation of common stock | 11,827 | 10,700 | — |
| Amortization of intangible assets | 8,126 | 2,167 | 2,362 |
| Depreciation expense | 2,860 | 4,368 | 3,231 |
| Amortization of deferred contract acquisition costs | 49,714 | 43,463 | 44,958 |
| Gain from deconsolidation of Arch, formerly Meltano | — | — | (17,798) |
| Loss from equity method investment | — | 3,824 | 3,189 |
| Impairment of equity method investment | — | 8,858 | — |
| Net amortization of premiums or discounts on short-term investments | (16,746) | (20,349) | (6,077) |
| Unrealized foreign exchange loss (gain), net | (9,526) | 4,833 | (3,964) |
| Other non-cash expense, net | 930 | 1,330 | 1,156 |
| Changes in assets and liabilities: | |||
| Accounts receivable | (99,649) | (36,341) | (54,169) |
| Prepaid expenses and other current assets | 8,424 | (23,688) | (8,679) |
| Deferred contract acquisition costs | (58,127) | (53,100) | (48,555) |
| Other non-current assets | (183) | (309) | 3,012 |
| Accounts payable | 5,505 | (3,443) | 287 |
| Accrued expenses and other current liabilities | (253,369) | 259,445 | 5,722 |
| Accrued compensation and benefits | 4,743 | 15,173 | (11,693) |
| Deferred revenue | 108,743 | 79,347 | 73,003 |
| Other non-current liabilities | (7,773) | 5,249 | (2,446) |
| Net cash provided by (used in) operating activities | (63,971) | 35,040 | (77,408) |
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||
| Purchases of short-term investments | (707,698) | (815,697) | (821,622) |
| Proceeds from maturities of short-term investments | 708,382 | 734,007 | 231,626 |
| Purchases of property and equipment | (3,765) | (1,598) | (6,070) |
| Deconsolidation of Arch, formerly Meltano | — | — | (9,620) |
| Payments for business combination, net of cash acquired | (20,210) | — | — |
| Payments for asset acquisition | (7,660) | — | — |
| Escrow payment related to business combination, after acquisition date | — | (2,500) | — |
| Other investing activities | 457 | (450) | — |
| Net cash used in investing activities | (30,494) | (86,238) | (605,686) |
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||
| Proceeds from the issuance of common stock upon exercise of stock options, including early exercises, net of repurchases | 23,964 | 32,302 | 24,515 |
| Issuance of common stock under employee stock purchase plan | 13,556 | 12,933 | 14,378 |
| Contributions received from noncontrolling interests, net of issuance costs | — | — | 61,726 |
| Settlement of acquisition related contingent cash consideration | (4,900) | — | (3,137) |
| Net cash provided by financing activities | 32,620 | 45,235 | 97,482 |
| Impact of foreign exchange on cash and cash equivalents | 1,498 | (3,943) | (3,658) |
| Net decrease in cash and cash equivalents | (60,347) | (9,906) | (589,270) |
| Cash and cash equivalents at beginning of period | 287,996 | 297,902 | 887,172 |
|---|---|---|---|
| Cash and cash equivalents at end of period | $227,649 | $287,996 | $297,902 |
| Supplemental disclosure of cash flow information: | |||
| Cash paid for income taxes related to the bilateral advance pricing agreement | $187,735 | $— | $— |
| Other cash paid for income taxes | $3,095 | $6,903 | $838 |
| Supplemental disclosure of non-cash investing and financing activities: | |||
| Acquisition measurement period adjustment | $310 | $— | $— |
| Vesting of early exercised stock options | $341 | $1,234 | $4,706 |
| Unpaid property and equipment in accounts payable | $247 | $— | $— |
| Reconciliation of cash, cash equivalents and restricted cash within the consolidated balance sheets to the amounts shown in the statements of cash flows above: | |||
| Cash and cash equivalents | $227,649 | $287,996 | $295,402 |
| Restricted cash, included in prepaid expenses and other current assets | — | — | 2,500 |
| Total cash, cash equivalents and restricted cash | $227,649 | $287,996 | $297,902 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.